Background/Aims: Borrelia burgdorferi spirochete has been found both in bladder biopsies and the urine of patients with Lyme disease (LD) as well as in experimental animals. The urological symptoms in borreliosis resemble those of interstitial cystitis (IC): frequency, urgency and nocturia. The aim of this studies is to find the role of B. burgdorferi in interstitial cystitis.Methods: We studied antibodies against B. burgdorferi from serum samples of 50 IC patients with two separate EIA tests. Patients with positive serology in both tests underwent cystoscopy and a bladder biopsy was taken. The presence of borrelia DNA was studied with borrelia–specific polymerase chain reaction (PCR), and with universal bacterial PCR.Results: IgM class antibodies to B. burgdorferi were not found, but IgG antibodies were found in four samples (8%). This was higher than in the control material (2%). One patient’s sample was strongly positive, whereas three samples were weakly positive. Bladder biopsies taken from the 4 patients were negative for borrelia DNA in both PCR tests. None of the seropositive patients had any symptoms consistent with LD.Conclusion: These results indicate that persistent infection of B. burgdorferi has no role in the etiology of IC. On the other hand a connection with a past borrelia infection and IC is not excluded.

Keywords:
Bladder, Cystitis, interstitial, Lyme disease, Borrelia burgdorferi
1.
Ratliff TL, Klutke CG, McDougal EM: The etiology of interstitial cystitis. Urol Clin North Am 1994;21:21–30.
2.
Holm–Bentzen M: Pathology, pathophysiology, and pathogenesis of painful bladder diease. Urol Res 1989;17:203–206.
3.
Koziol JA, Clark DC, Gittes RF, Tan EM: The natural history of interstitial cystitis: A survey of 374 patients. J Urol 1993;149:465–469.
4.
Jokinen EJ, Alftan OS, Oravisto KJ: Antitissue antibodies in interstitial cystitis. Clin Exp Immunol 1972;11:333–339.
5.
Hanash KA, Pool TL: Interstitial and hemorrhagic cystitis: Viral, bacterial and fungal studies. J Urol 1970;104:705–706.
6.
Fall M, Johansson SL, Vahlne A: A clinicopathological and virological study of interstitial cystitis. J Urol 1985;133:771–773.
7.
Hedelin HH, Mardh P–A, Brorson J–E, Fall M, Möller BR, Pettersson KGS: Mycoplasma hominis and interstitial cystitis. Sex Transm Dis 1983;10(suppl 4):327–330.
8.
Haarala M, Jalava J, Laato M, Kiilholma P, Nurmi M, Alanen A: Absence of bacterial DNA in the bladder of patients with interstitial cystitis. J Urol 1996;156:1843–1845.
9.
Domingue GJ, Ghoniem GM, Bost KL, Fermin C, Human LG: Dormant microbes in interstitial cystitis. J Urol 1995;153:1321–1326.
10.
Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davies JP: Lyme disease: A tick–borne spirochetosis? Science 1982;216: 1317–1319.
11.
Steere AC, Grodzicki RL, Kornblatt AN, Craft JE, Barbour AG, Burgdorfer W, Schmid GP, Johnson E, Malawista SE: The spirochetal etiology of Lyme disease. N Engl J Med 1983; 308:733–740.
12.
Steere AC: Lyme disease. N Engl J Med 1989; 321:586–596.
13.
Öhman C: The geographical and topographical distribution of Ixodes ricinus in Finland. Acta Soc Fauna Flora Fenn 1961;76:1–26.
14.
Brummer–Korvenkantio M: Tick ecology and virus isolations from ticks in Finland; in Corradetti A (ed): Proc 1st Int Congr Parasitol Rome 1964, 1996, vol 2, pp 1044–1045.
15.
Junttila J, Tanskanen R, Tuomi J: Prevalence of Borrelia burgdorferi in selected tick populations in Finland. Scand J Infect Dis 1994;26: 349–355.
16.
Stechenberg BW: Lyme disease: The latest great imitator. Infect Dis J 1988;7:402–409.
17.
Duray PH: Clinical pathologic correlations of Lyme disease. Rev Infect Dis 1989;11(suppl 6): 1487–1493.
18.
Schwan TG, Burgdorfer W, Schrumpf ME, Karstens RH: The urinary bladder, a consistent source of Borrelia burgdorferi in experimentally infected white–footed mice (Peromyscus leucopus). J Clin Microbiol 1988;26:893–895.
19.
Goodman JL, Jurkovich P, Kodner C, Johnson RC: Persistent cardiac and urinary tract infections with Borrelia burgdorferi in experimentally infected Syrian hamsters. J Clin Microbiol 1991;29:894–895.
20.
Goodman JL, Jurkovich P, Kramber JM, Johnson RC: Molecular detection of persistent Borrelia burgdorferi in the urine of patients with active Lyme disease. Infect Immun 1991;59: 269–278.
21.
Chancellor MB, McGinnis DE, Shenot PJ, Kiilholma P, Hirsch IH: Urinary dysfunction in Lyme disease. J Urol 1993;149:26–30.
22.
Gallister SM, Agger WA, Schell RF, Brand KM: Efficacy of the urinary bladder for isolation of Borrelia burgdorferi from naturally infected, wild Peromyscus leucopus. J Clin Microbiol 1989;27:773–774.
23.
Dorward DW, Schwan TG, Garon CF: Immune capture and detection of Borrelia burgdorferi antigens in urine, blood, or tissues from infected ticks, mice, dogs, and humans. J Clin Microbiol 1991;29:1162–1170.
24.
Hyde FW, Johnson RC, White TJ, Shelburne CE: Detection of antigens in urine of mice and humans infected with Borrelia burgdorferi, etiologic agent of Lyme disease. J Clin Microbiol 1989;27:58–61.
25.
Duray PH: Clinical pathologic correlations of Lyme disease. Rev Infect Dis 1989;11:1487– 1493.
26.
Dressler F, Whalen JA, Reinhardt BN, Steere AC: Western blotting in serodiagnosis of Lyme disease. J Infect Dis 1993;167:392–400.
27.
Gillenwater JY, Wein AJ: Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Disease Workshop on Interstitial Cystitis. National Institutes of Health, Bethesda, Maryland, August 28–29 1987. J Urol 1988;140:203–206.
28.
Viljanen MK, Punnonen J: The effect of storage of antigen–coated styrene microwells on the detection of antibodies against Borrelia burgdorferi by enzyme immunoassay (EIA). J Immunol Methods 1989;124:137–141.
29.
Schmidt B, Muellegger RR, Stockenhuber C, Soyer HP, Hoedl S, Luger A, Kerl H: Detection of Borrelia burgdorferi–specific DNA in urine specimens from patients with erythema migrans before and after antibiotic therapy. J Clin Microbiol 1996;34:1359–1363.
30.
Hansen K, Hindersson P, Strandberg–Pedersen N: Measurement of antibodies to the Borrelia burgdorferi flagellum improves serodiagnosis in Lyme disease. J Clin Microbiol 1988;26: 338–346.
31.
Hofmann H: Lyme borreliosis: Problems of serological diagnosis. Infection 1996;24:470– 472.
32.
Karlsson M: Western immunoblot and flagellin enzyme–linked immunosorbent assay for serodiagnosis of Lyme borreliosis. J Clin Microbiol 1990;28:2148–2150.
33.
Hansen K, Asbrink E: Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans by the Borrelia burgdorferi flagellum enzyme–linked immunosorbent assay. J Clin Microbiol 1989;27:545–551.
34.
Ratliff TL, Klutzke CG, Hofmeister M, Fang H, Russell JH, Becic MJ: Role of the immune response in interstitial cystitis. Clin Immunol Immunopathol 1995;74:209–216.
35.
Kirchner JT: Reiter’s syndrome. A possibility in patients with reactive arthritis. Postgrad Med 1995;97:111–112.
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.